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Abstract 
We studied how the release of histamine and prostaglandin D 2 (PGD 2) were connected in stimulated rat peritoneal mast cells, and to 
what extent hese processes were., controlled by the cytosolic Ca 2+ concentration, [Ca2+ ]i , and protein tyrosine kinases. In the presence of 
1 mM CaC12, the G-protein activating compound 48/80 (10 pg/ml )  evoked a transient rise in [Ca 2+ ]i and a relatively high secretion of 
histamine, but only a low release of PGD 2. In contrast, 5 /xM thapsigargin (an inhibitor of endomembrane Ca2+-ATPases) and 5 pM 
ionomycin evoked high and prolonged rises in [Ca 2+ ]i, and stimulated the cells to release relatively small amounts of histamine and high 
amounts of PGD 2. Stimulation of the cells with CaCl 2 and 10 ttM ATP 4- gave only minor quantities of histamine and PGD2, despite of 
the micromolar level of [Ca 2+ ]i reached. When CaCI 2 was replaced by EGTA, rises in [Ca 2+ ]i as well as release of histamine and PGD 2 
were reduced with each agonist., but the preference of agonists to release more histamine or PGD 2 remained unchanged. In mast cells 
with depleted Ca 2÷ stores, the addition of CaCl 2 stimulated the store-regulated Ca2+ entry resulting in a prolonged rise in [Ca2+]i . 
However, simultaneous addition of compound 48/80 and CaCl 2 was required for release of histamine and PGD 2. In cells with full stores, 
PGD 2 release evoked by compound 48/80 was greatly reduced by genistein and methyl-2,5-dihydroxycinnamate, two structurally 
unrelated inhibitors of protein tyrosine kinases, whereas histamine secretion was not influenced by these inhibitors. Similarly, with 
thapsigargin or ionomycin as agonist, PGD 2 release was more sensitive to the tyrosine kinase inhibitors than histamine secretion. We 
conclude that in activated rat peritoneal mast cells: (i) the influx of extracellular Ca 2+ potentiates agonist-evoked rises in [Ca2+]i as well 
as histamine secretion and PGD 2 release; (ii) the amplitude of the [Ca 2+ ]i rise does not determine the preferential effect of agonists to 
release more histamine or more PGD2; (iii) the relatively high PGD z release voked by thapsigargin and ionomycin is probably due to 
their potency to evoke a prolonged rise in [Ca 2÷ ]i and to activate protein tyrosine kinases. 
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1. Introduction 
Mast cells play important roles in processes like inflam- 
mation, anaphylaxis and asthma [1]. Activation of these 
cells results in the release of compounds like histamine 
and prostaglandin D 2 (PGD2), which induce vasodilation, 
increased vascular permeability and bronchoconstriction 
Abbreviations: [Ca 2+ ]i, cytosolic-free Ca 2+ concentration; Hepes, 
4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; MAP kinase, mito- 
gen-activated protein kinase; PGD2, prostaglandin D 2. 
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[2,3]. Histamine and PGD 2 are released from activated 
mast cells by two quite different mechanisms. Histamine is 
stored in the intracellular secretory granules and is released 
into the extracellular medium by exocytosis. It is generally 
accepted that both elevation in the cytosolic Ca 2+ concen- 
tration ([Ca2+]i) and activation of the protein kinase C 
pathway are important in triggering the exocytotic event 
[4,5]. The heterotrimeric G protein, Gi3 , probably plays an 
additional role in this process [6]. On the other hand, the 
principle route to produce PGD 2 is most likely by activa- 
tion of phospholipase A 2, a Ca 2 +-dependent enzyme which 
liberates arachidonic acid from the membrane phospho- 
lipids [7,8]. 
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The observation that stimulation of peritoneal mast cells 
with G protein-activating compounds (e.g. substance P or 
compound 48/80) and with typically Ca2+-mobilizing 
compounds (e.g. the Ca 2÷ ionophore A23187) evokes both 
histamine secretion and PGD 2 release [9], may suggest that 
these two processes are activated by common signal trans- 
duction pathways and that elevation in [cae+] i is part of 
this common mechanism. Indeed, one research group has 
even proposed that both pathways may coincide and PGD 2 
release be largely secondary to exocytosis [10]. However, 
ample evidence has been presented by others that his- 
tamine secretion and PGD 2 release occur independently of
each other and have to be regulated in different ways. For 
instance, it was found that stimulation of rat peritoneal 
mast cells with anti-immunoglobulin E or A23187 resulted 
in a relatively high PGD 2 release and a moderate his- 
tamine secretion [9,11,12], whereas stimulation with 
bradykinin, substance P or compound 48/80 gave a much 
lower PGD 2 release and increased histamine secretion 
[9,11]. Comparable results have been obtained with human 
skin mast cells [13-15]. 
In rat peritoneal mast cells, the release of both his- 
tamine and PGD 2 is known to be initiated after [Ca 2÷ ]i is 
increased from basal (50-100 nM) to higher levels [12,16]. 
Nevertheless, the time intervals in which these two release 
processes take place are often different. With various 
agonists including compound 48/80, histamine secretion 
is detectable already at seconds after the elevation of 
[Ca2+] i [16], whereas PGD 2 generation starts after a lag 
time of tens of seconds [9,17]. An exception appears to be 
the ionophore A23187, which was found to evoke a grad- 
ual and simultaneous release of both compounds that 
persisted several minutes [9,12]. Together, this suggests 
that either release process may require different ypes of 
Ca 2÷ responses which, indeed, has been reported for mast 
cells stimulated with A23187 [12]. 
In this paper, we determined the relationship between 
histamine secretion and PGD 2 release after the stimulation 
of rat peritoneal mast cells with different ypes of agonists, 
and questioned to what extent hese processes were related 
to the amplitude and shape of the agonist-evoked levation 
in [Ca 2÷ ]i. Therefore, we loaded mast cells with fura-2 and 
measured the released products after stimulation with ago- 
nists that directly or indirectly influenced intracellular 
Ca 2÷ homeostasis. Ceils were stimulated in the presence 
of absence of CaC12 with compound 48/80, known to 
activate phospholipase C in a G protein-dependent way 
[18,19] and with thapsigargin, an inhibitor of the en- 
domembrane Ca2+-ATPases, which in many cell types 
activates the so-called store-regulated Ca2+ influx pathway 
independently of phospholipase C [20,21]. Mast cells were 
also stimulated with agents directly permeating the plasma 
membrane for Ca 2+, i.e. the Ca2+-ionophore ionomycin 
and the Mg2+-free form of ATP, ATP 4-. The latter com- 
pound opens specific pores in the plasma membrane fol- 
lowing binding to a P2y-SUbtype purinergic receptor [22,23]. 
Since in a variety of cell types protein tyrosine kinases are 
likely to be involved in the activation of phospholipase A 2 
[24], arachidonic acid release [25,26] and eicosanoid for- 
mation [27,28], we also questioned to what extent the 
differential ability of agonists to release more histamine or 
PGD 2 may be due to the activation of these kinases. Two 
structurally dissimilar inhibitors of protein tyrosine ki- 
nases, genistein and methyl-2,5-dihydroxycinnamate, 
which have been extensively tested in a number of cell 
types [28-31], were used to answer this question. 
Our results indicate that the store-regulated Ca2+ influx 
pathway represents a major contribution to the Ca 2÷ signal 
evoked by compound 48/80 and thapsigargin, and that the 
influx of Ca e÷ potentiates both histamine secretion and 
PGD 2 release. However, we concluded that not the ampli- 
tude of the agonist-evoked Ca2÷ response, but, instead, the 
duration of this response in combination with a different 
involvement of protein tyrosine kinases in these two re- 
lease processes primarily determined the preferential re- 
lease of histamine or PGD 2. 
2. Materials and methods 
2.1. Chemicals 
Metrizamide was purchased from Nyegaard (Oslo, Nor- 
way). Bovine serum albumin, compound 48/80 (a conden- 
sation product of N-methyl-p-methoxy-phenethylamine 
with formaldehyde), thapsigargin and ATP 4- (used in the 
Mg2+-free form) were obtained from Sigma (St. Louis, 
MO, USA). Heparin (Thromboliquine ®)was from Organon 
Teknika (Boxtel, The Netherlands). Fura-2 acetoxymethyl 
ester and pluronic F-127 were from Molecular Probes 
(Eugene, OR, USA) and ionomycin was from Serva 
(Heidelberg, Germany). All chemicals were of analytical 
grade. Water was purified with a milli-Q purification unit 
from Millipore (Bedford, MA, USA). Methyl-2,5-dihy- 
droxycinnamate and genistein were obtained from Sigma 
and freshly dissolved into dimethyl sulfoxide before each 
experiment. 
2.2. Mast  cells 
Male Wistar retired breeder ats were obtained from 
Charles River Laboratories (Sulzfeld, Germany). Five to 
ten rats were used for each experiment. The rats, weighing 
250 to 350 g, were anaesthetized with diethyl ether and 
peritoneal mast cells were obtained as described earlier 
[32]. Briefly, after intraperitoneal injection of lavage buffer, 
composed of 136 mM NaC1, 2.7 mM KC1, 8.1 mM 
Na2HPO 4, 1.5 mM KH2PO 4, gelatin (1 mg/ml) and 
heparin (10 IE/ml) (pH 7.4), the abdomen was massaged 
and the peritoneal exudate was recovered. After centrifuga- 
tion a cell sediment was obtained, which was washed twice 
with lavage buffer. Mast cells were separated from other 
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nucleated cells by centrifugation at 470 X g for 15 min 
through a 22.5% (w/v)  metrizamide gradient in lavage 
buffer. After washing the sediment wice, contaminating 
erythrocytes were separated from the mast cells by centrif- 
ugation through a discontinuous 3%/9% (w/v)  metriza- 
mide gradient at 50 X g for 10 min. The sediment, contain- 
ing the mast cells, was washed twice with buffer (pH 7.4) 
containing 136 mM NaCI, 2.7 mM KC1, 10 mM Hepes and 
0.1% (w/v)  bovine serum albumin. The cells were finally 
resuspended into 3 ml buffer (pH 7.4), supplemented with 
5% (w/v)  bovine serum albumin and 5 mM glucose in a 
concentration f 2 .10  6 cells/ml. Cells were counted with 
a Coulter counter, model ZM (Coulter Electronics, Krefeld, 
Germany). Final purity of the mast cell preparations was 
> 99%, as determined by microscopy after staining with 
toluidine blue and May-Griinwald-Giemsa. Mean mast cell 
number obtained per rat was 8 .10  s, sufficient to carry out 
2-3 incubations. 
2.3. Fura-2 fluorescence measurements 
Suspended mast cells were loaded with fura-2 acetoxy- 
methyl ester (3 ~M) in the presence of the dispersing 
agent pluronic F-127 (1 mg/ml) under slow rotation at 
20°C for 45 min, as described earlier for rat platelets [33]. 
These conditions were used to prevent intracellular com- 
partmentalization f the probe. After centrifugation at 195 
X g for 5 min, the fura-2-1oaded cells were resuspended in 
buffer pH 7.4 in a concentration of 1. l0 s cells/ml. 
Changes in fura-2 fluorescence were measured at an emis- 
sion wavelength of 500 nm, while the excitation wave- 
length was switched continuously between 340 and 380 
nm. Fluorescence data were collected every 2 s and pro- 
cessed by a personal computer. Calibration values for the 
calculation of [Ca 2÷ ]i were collected after the addition of 
0.1% (w/v)  Triton X-100 or digitonin in the presence of 1 
mM CaC12, followed by 10 mM EGTA and 50 mM 
Tris-HC1 (pH 8.3), according to the procedure of 
Grynkiewicz et al. [34]. In all experiments, we checked for 
possible compartmentalization of the loaded fura-2: ATP 4- 
(10 /xM) in the presence of 1 mM CaCI 2 always evoked 
an immediate and high Ca 2÷ response, indicating that most 
of the dye was located in the cytosol. 
2.4. Mast cell activation 
Fura-2-1oaded cells (2.5.105 cells/2.5 ml) were acti- 
vated in plastic cuvettes at a stirring rate of 150 rpm at 
37°C. Agonists were added from 1000-fold stock solutions 
in doses required to induce maximal Ca 2+ responses at 
this cell concentration. Calcium measurements were per- 
formed continuously or at certain time intervals, as indi- 
cated. Samples of 500 /xl were withdrawn from the incu- 
bations, immediately layered onto 200 /zl of silicon oil 
(d = 1.049) and centrifuged in an Eppendorf centrifuge at 
15 000 x g for 10 s. The supernatants were collected for 
the determination f histamine or PGD 2, and were stored 
at -70°C until analysis. Samples for analysis of PGD 2 
were methoximated directly after the experiment, accord- 
ing to the instructions of the kit. Total releasable histamine 
was measured by solubilization of a subsample of the cells 
with 0.1% (w/v)  Triton X-100 and centrifugation f resid- 
ual cell material at 15 000 × g for 10 s. The degrees of 
histamine secretion and PGD 2 release were corrected for 
the amounts of histamine and PGD 2 present in the super- 
natant of unstimulated cells, which values were constant 
within each experiment and attributed to < 7% of total 
releasable histamine and < 2 ng PGD2/106 cells, respec- 
tively. The lower detection limits were 0.3% of total 
releasable histamine and 1 ng PGD2/106 cells. 
2.5. Store-depleted mast cells 
Mast cells with depleted Ca 2+ stores were prepared for 
some experiments. To this end, the cells were loaded with 
fura-2 as described above, except hat ionomycin (5 /.~M), 
thapsigargin (100 nM) and EGTA (0.2 mM) were added 
15 min after the addition of the fura-2 acetoxymethyl ester. 
These additions did not interfere with the uptake or 
deesterification f the fura-2 ester and resulted in a deple- 
tion of the intracellular store content of 85 _ 5% and in a 
reduction of the releasable histamine content of 15 __ 5% 
(mean _+ S.D., n -- 4). After 30 min of incubation, the cells 
were centrifuged at 195 X g for 5 min, washed with buffer 
(pH 7.4) and resuspended at a concentration of 1.106 
cells/ml. The content of the internal Ca 2+ stores was 
estimated from the maximal increase in [Ca 2+ ]i evoked by 
ionomycin (5 /zM) in the presence of EGTA (1 raM). 
Because of the low dose of thapsigargin used during the 
store depletion procedure, the mast cells still responded 
well to higher doses and to compound 48/80. 
2.6. Determination of PGD 2 and histamine 
PGD 2 was measured with an enzyme-linked immunoas- 
say kit purchased from Cayman Chemical (Ann Arbor, MI, 
USA). Histamine was determined by a HPLC-method 
described earlier [35]. Briefy, after the addition of the 
internal standard 1-methyl histamine, samples were puri- 
fied and concentrated on carboxylic acid cation exchange 
columns. Histamine and 1-methyl histamine were eluted 
with 1 M HC1. After drying under nitrogen at 40°C, the 
samples were redissolved into 500 /zl of a 40 mM sodium 
borate buffer (pH 9.1) and the samples were derivatized 
with 500 /xl of a freshly prepared fluorescamine solution 
(0.2 mg/ml  acetonitrile). The derivatives were dried under 
nitrogen and redissolved into 1 ml of the HPLC elution 
phase consisting of water/acetonitrile/methanol/14.8 M 
phosphoric acid (750:150:100:2, v/v) ,  brought at pH 6.87 
with NH4OH. Separation was performed at 20°C on a 
reversed phase Inertsil ODS-2 column (200 X 3 mm inter- 
nal diameter, 5 /xm particles) from Chrompack (Middel- 
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Fig. 1. Calcium responses of mast cells in the presence of EGTA. Fura-2-1oaded mast cells were stimulated with (A) compound 48/80 (10 p,g/ml), (B) 
thapsigargin (5 /xM), (C) ionomycin (5 /zM) or (D) ATP 4- (10 y,M) in the presence of 1 mM EGTA. Tracings are shown of changes in [Ca 2. ]i, 
representative for six experiments. Arrows indicate the addition of agonists. 
burg, The Netherlands). The injection volume was 20 /zl 
and flow rate was 0.4 ml/min.  Fluorescence was detected 
at excitation and emission wavelengths of 360 and 440 nm, 
respectively. Samples were kept in an auto-injector in the 
dark at 4°C. Data were processed as described before [36]. 
2.7. Statistical analysis 
To evaluate the effects of inhibitors, data were com- 
pared to those of control incubations, using the variance 
analysis of Bonferoni [37]. 
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Fig. 2. Calcium responses of mast cells in the presence of CaC12. Fura-2-1oaded mast cells were stimulated with (A) compound 48/80 (10 /xg/ml), (B) 
thapsigargin (5 /xM), (C) ionomycin (5 /xM) or (D) ATP 4- (10 /zM) in the presence of 1 mM CaC12. Tracings are shown of changes in [Ca2+]i, 
representative for six experiments. Note the different scale of the Y-axis in comparison with Fig. 1. 
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3. Results 
3.1. Calcium responses of rat' peritoneal mast cells 
Fura-2-1oaded mast cells were stimulated with non-lytic 
doses of various agonists in the presence of EGTA or 
CaC12, and changes in [Ca2+]i were measured by spec- 
trofluorometry. Agonists were added in doses evoking 
maximal Ca 2÷ responses at a cell concentration of 1. 
105/ml. Calcium responses with 1 mM EGTA were con- 
sidered to reflect the release of Ca 2+ from internal Ca 2+ 
stores into the cytosol, and the responses in the presence of 
1 mM CaC12 both internal Ca 2+ mobilization and influx of 
Ca 2+ from the extracellular medium. Fig. 1 shows typical 
time courses of cells stimulated in the presence of EGTA. 
Compound 48/80  (10 /xg/ml)  gave a rapid and transient 
increase in [Ca2+] i (Fig. 1A), probably caused by 
Ins(1,4,5)-P3-evoked depletion of the intracellular Ca 2+ 
stores [18,19]. Stimulation with thapsigargin (5 /zM) re- 
suited in a slow and prolonged rise in [Ca 2÷ ]i (Fig. 1B), 
pointing to gradual depletion of the Ca 2÷ stores by inhibi- 
tion of the thapsigargin-sensitive Ca2+-ATPases in the 
store membranes. Stimulation with the Ca 2+ ionophore 
ionomycin (5 /zM)  resulted in an increase in [Ca 2+ ]i which 
was transient in four out of six experiments (Fig. 1C) and 
was not reversed in the two other experiments. The 
Mg2+-free ATP 4- (10 /xM) gave no significant Ca 2÷ 
response in the presence of EGTA (Fig. 1D), indicating 
that ATP  4- at this concentration did not evoke store 
depletion. 
In the presence of CaC12, stimulation of the cells with 
compound 48/80  (10 /xg/ml)  resulted in a transient 
increase in [Ca2+] i with a similar shape but of almost 
ten-fold higher amplitude than the transient seen in the 
absence of extracellular Ca 2÷ (Fig. 2A). Similarly, thapsi- 
gargin induced comparably shaped Ca 2÷ signals in the 
presence (Fig. 2B) and absence (Fig. 1B) of CaC12, al- 
though the level of [Ca 2÷ ]i reached was much higher when 
CaC12 was present. Stimulation of the cells with iono- 
mycin and CaCI 2 resulted in a micromolar [Ca 2+ ]i which 
remained high for at least 3 min. (Fig. 2C). ATP 4- in 
combination with CaCI 2 gave an immediate and high 
increase in [Ca2+] i (Fig. 2D), indicating that this agonist 
promoted the influx of Ca 2+, despite its inability to evoke 
store depletion (Fig. 1D). 
So far, the results suggested that the depletion of the 
intracellular Ca 2÷ stores by compound 48/80  and thapsi- 
gargin was accompanied by a considerable influx of Ca 2 ÷ 
from the extracellular medium. Additional support that 
these agonists opened divalent cation channels in the 
plasma membrane came from experiments, where the 
quenching of fura-2 fluorescence caused by the agonist- 
evoked entry of Mn 2+ was measured (data not shown). 
Furthermore, the Ca 2+ entry blocker NiC12 (5 mM) ap- 
peared to inhibit the CaCl2-dependent part of the Ca 2÷ 
responses evoked by both compound 48/80  and thapsigar- 
gin (data not shown). 
3.2. Calcium responses, histamine secretion and PGD 2 
release 
Using fura-2-1oaded mast cells, we compared the rises 
in [Ca2+]i with the potency of the agonists to release 
histamine and PGD 2 under conditions where Ca 2÷ influx 
was present or absent. Therefore, the cells were incubated 
at 37°C under stirring and, at 2 and 10 min after the 
addition of agonists, [Ca2+] i was measured after which 
samples were taken from the incubation mixture for the 
determination of extracellular histamine and PGD 2. The 
results are shown in Table 1. When extracellular Ca 2+ was 
chelated with EGTA, stimulation with compound 48/80  
(10 /xg/ml)  resulted in a relatively high histamine secre- 
tion (20% of total releasable histamine after 10 min of 
activation), but in a low PGD 2 release (below the detection 
limit of 1 ng/106 cells). Stimulation with thapsigargin (5 
/zM) and EGTA resulted in a somewhat lower histamine 
secretion (15% of total histamine), whereas the PGD 2 
release was relatively high (10 ng/106 cells). In the 
Table 1 
Effects of various agonists on [Ca 2+ ]i, histamine secretion and PGD 2 release 
Agonist Addition Increase in [Ca 2 + ]i (riM) Histamine secretion (% of total) PGD 2 release (rig/10 6cells) 
2 min 10 min 2 min 10 min 2 min 10 min 
Compound 48/80 CaC12 496 _+ 57 275 _+ 37 68 _+ 5 72 _+ 5 4 + 1 7 _+ 1 
EGTA 30 + 2 5 _ 3 17_ 4 20 + 4 < 1 < 1 
Thapsigargin CaCI 2 460 + 140 1156 + 314 15 + 2 18 -I- 2 13 + 2 15 + 2 
EGTA 71 + 20 90_ 17 5 _ 1 15 _ 2 9 + 2 10 + 3 
Ionomycin CaC12 691 + 215 869 + 579 9 _ 3 13 + 3 22 + 3 30 + 2 
EGTA 33 _+ 11 29 + 7 < 0.3 < 0.3 < 1 < 1 
ATP 4-  CaC12 896 + 117 1420 + 210 5 ± 1 4 ± 2 < 1 < 1 
EGTA 11 ± 11 12 ± 12 < 0.3 < 0.3 < 1 < 1 
Mast cells were stimulated with compound 48/80 (10 /zg/ml), thapsigargin (5 /zM), ionomycin (5 /~M) or ATP  4-  (10 /xM) in the presence of 1 mM 
CaC12 or 1 mM EGTA, as indicated. Agonist-evoked increase in [Ca 2+ ]i, secretion of histamine (% of total releasable histamine) and release of PGD 2 (ng 
released/106 cells) were determined at2 and 10 min after the onset of activation. Detection limits were for histamine secretion 0.3% and for PGD 2 
release 1ng/106 cells. Data given are mean values + S.E. (n ~ 4). 
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Table 2 
Rises in [Ca 2+ ]i, histamine secretion and PGD 2 release in store-depleted mast cells 
Addition Increase in [Ca 2+ ]i (nM) 
2 min 10 min 
Histamine secretion (% of total) PGD 2 release (ng/10 6 cells) 
2 min 10 min 2 min 10 min 
CaC12 325 -t- 94 309 + 123 2 4- 1 2 4- 1 4 ___ 1 5 4- 1 
Compound 48/80 24 _+ 5 * 38 + 4 * < 0.3 < 0.3 < 1 < 1 
CaC1 a + compound 48/80 613 _+ 68 392 + 53 59 4- 3 56 4- 4 38 -I- 14 44 4- 17 
Fura-2-1oaded mast cells were prepared that were depleted in Ca 2+ stores, as described in Section 2. The responses evoked by the addition of CaCI 2 (1 
mM) and/or compound 48/80 (10 ~*g/ml) were determined after 2 and 10 min. Data are presented as indicated in Table 1. Results are mean 
values + S.E. (n = 3). 
* Control incubations without compound 48/80 showed an equal rise in [Ca 2+ ]i. 
presence of CaC12, the release of both histamine and 
PGD 2 appeared to be potentiated, when compared to the 
EGTA-containing incubations. Compound 48/80 with 
CaC12 evoked, again, a relatively high histamine secretion 
(72% of total histamine) and low PGD 2 release (7 ng/106 
cells); thapsigargin with CaC12, again, was less efficient in 
evoking the release of histamine (18% of total) than of 
PGD 2 (15 ng/106 cells). Apparently, with either agonist 
histamine secretion and eicosanoid formation were potenti- 
ated by the higher levels of [Ca 2÷ ]i reached by the entry of 
extracellular Ca 2+. This conclusion was supported by the 
observation that the addition of NiCI 2 significantly re- 
duced the release of the mast cell products induced by 
compound 48/80 and CaC12 (data not shown). 
In the presence of EGTA, ionomycin (5 /xM) and 
ATP 4- (10 /xM) were unable to evoke significant forma- 
tion of histamine or PGD 2 (Table 1). With CaCI 2, how- 
ever, ionomycin did promote the release of relatively low 
amounts of histamine (13% of total releasable histamine) 
and high amounts of PGD 2 (30 ng/106 cells). In contrast, 
ATP 4- gave only a marginal secretion of histamine (4% 
of total) and no PGD 2 release, despite the high, micromo- 
lar level of [Ca 2+ ]i reached under this condition. 
Taken together, these results indicate that stimulation of 
the mast cells with compound 48/80 favoured the release 
of histamine, whereas timulation with the Ca 2÷ mobiliz- 
ers thapsigargin and ionomycin resulted in a more efficient 
release of PGD 2. ATP 4- (10/xM) was a rather ineffective 
inducer for either process. Since the rises in [Ca 2÷ ]i ob- 
tained with thapsigargin and ionomycin were more pro- 
longed than the rises with compound 48/80 (Table 1 and 
Fig. 2), it is tempting to suggest hat the relatively high 
PGD 2 release seen with the Ca 2+ mobilizers is related to 
the long duration of the Ca 2÷ signal. On the other hand, 
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Fig. 3. Effects of protein tyrosine kinase inhibitors on the histamine secretion and PGD 2 release by stimulated mast cells. Mast cells were pre-incubated 
with 0.2% (v/v)  dimethyl sulfoxide (DMSO, vehicle control), with 5 /zM methyl-2,5-dihydroxycinnamate (DHC) or with 100 /zM genistein (GS) during 
45 min. The cells were subsequently stimulated with 10/xg/ml  compound 48/80 or with 5 p,M thapsigargin the presence of 1 mM CaCl 2. The release 
of histamine and PGD 2 from the cells was determined at 10 min after activation. Data (means + S.E., n = 4) represent histamine secretion (A, B) and 
PGD 2 release (C, D), expressed as the percentage of total releasable histamine and ng PGD2/106 cells, respectively. Asterisks indicate statistically 
significant differences (P  < 0.05) compared to control cells. 
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the results do not suggest that the amplitude of the [Ca 2+ ]i 
signal may determine the preferential ction of the agonists 
to release more histamine or PGD 2 since, in general, this 
preference was the same in the presence and absence of 
extracellular CaC12, where Ca 2÷ influx did or did not 
amplify the signal. 
mate and genistein (Fig. 3B), in contrast o the PGD 2 
release which, again, was potently inhibited (Fig. 3D). 
Similar effects of these tyrosine kinase inhibitors were 
found, when the cells were stimulated with ionomycin 
instead of thapsigargin (data not shown). 
3.3. Histamine secretion and PGD 2 release by store-de- 
pleted mast cells 
To further investigate the significance of Ca 2+ influx 
for histamine secretion and PGD 2 release, fura-2-1oaded 
mast cells were prepared with depleted Ca 2÷ stores (see 
Section 2). Stimulation of these store-depleted cells with 
ionomycin in the presence of EGTA resulted in a maximal 
increase in [Ca 2÷ ]i which was only 15 + 5% (mean + S.E., 
n = 3) of the increase seen in untreated control cells, 
indicating that most of the intracellular Ca 2+ was removed 
by the depletion procedure. Determination f the histamine 
content in the store-depleted cells learned that no more 
than 15 ___ 5% of the total releasable histamine was lost by 
the procedure. 
When 1 mM CaC12 was added to the store-depleted 
mast cells, this resulted in an immediate and prolonged 
increase in [Ca 2÷ ]i of about 300 nM (Table 2), due to the 
influx of extracellular Ca 2+ through the store-regulated 
entry pathway. Using control cells with full Ca 2+ stores, 
the addition of CaC12 resulted in a [Ca 2÷ ]i rise of only 10 
nM. Despite the high Ca 2÷ response in the store-depleted 
cells, CaC12 addition resulted in only a marginal release of 
histamine and PGD 2 (Table 2). Apparently, the influx of 
Ca 2÷ and the resulting increase in [Ca2+] i were insuffi- 
cient to promote substantial release of these compounds. 
When compound 48//80 was added to the store-depleted 
cells, no Ca 2÷ signal was detected and neither histamine 
nor PGD 2 were released (Table 2). However, when com- 
pound 48//80 was added with CaC12, a sustained increase 
in [Ca 2÷ ]i was accompanied by a high histamine secretion 
(56% of total releasable histamine) and high PGD 2 release 
(44 ng//106 cells). 
3.4. Effects of protein tyrosine kinase inhibitors on the 
release of histamine and PGD 2 by mast cells 
We studied the role of protein tyrosine kinases in the 
release of histamine and PGD 2 from mast cells by using 
two structurally unrelated inhibitors of these signalling 
components, methyl-2,5-dihydroxycinnamate and genis- 
tein. After pre-incubation with these inhibitors, the mast 
cells were stimulated with compound 48//80 or thapsigar- 
gin in the presence of CaC12. The histamine secretion 
induced by compound 48//130 appeared not to be influ- 
enced by either inhibitor (Fig. 3A), whereas the PGD 2 
release by this agonist was considerably reduced (Fig. 3C). 
With thapsigargin as agonist, histamine secretion was 
slightly influenced by both methyl-2,5-dihydroxycinna- 
4, Discussion 
4.1. Role of store-regulated Ca 2 + influx in histamine and 
PGD 2 release 
Activation of rat peritoneal mast cells with the G-pro- 
tein activating compound 48//80 and the endomembrane 
Ca2+-ATPase inhibitor thapsigargin resulted in Ca 2÷ sig- 
nals, which consisted of a relatively small component 
representing mobilization of Ca 2+ from internal stores and 
a larger component representing influx of Ca 2+ from the 
extracellular medium (Figs. 1 and 2). A body of data 
suggested that the influx with these agonists amplified the 
rises in [Ca2+] i evoked by store depletion and occurred 
through the store-regulated influx pathway: (i) both with 
compound 48//80 and the endomembrane-active thapsigar- 
gin, the [Ca 2÷ ]i rises were of similar shape in the presence 
and absence of CaCI2, notwithstanding the higher ampli- 
tude reached with CaC12 (Figs. 1 and 2); (ii) when extra- 
cellular Ca 2+ was present, only the CaCl2-dependent part 
of [Ca 2÷ ]i rises was suppressed by the Ca 2÷ entry blocker 
Ni 2+, (iii) in mast cells with depleted Ca 2÷ stores, addi- 
tion of CaC12 was sufficient o evoke an immediate and 
high increase in [Ca2+] i (Table 2), as predicted by the 
store-regulated pathway. In many other cells types in 
which this influx pathway is identified, including the rat 
mastocytoma cell line RBL-2H3 [38-41], similarly, store- 
regulated influx is known to be initiated by G protein- 
mediated activation of phospholipase C and by inhibition 
of thapsigargin-sensitive Ca2+-ATPases in the store mem- 
branes. In peritoneal mast cells, this influx pathway has 
already been detected in electrophysiological studies, where 
specific inward Ca 2+ currents were measured following 
depletion of the Ca 2÷ stores [42,43]. The mechanism 
responsible for this type of Ca 2+ influx is still unclear, 
although some proposals have been made, such as the 
release of an intermediary messenger other than Ca 2+ 
from the store compartments [38,44]. 
Our data indicate that the relatively high levels of 
[Ca2+]i caused by entry of external Ca 2+ potentiated the 
secretion of both histamine and PGD 2 from the mast cells 
(Table 1). On the other hand, there were several activation 
conditions, where a considerable increase in [CaZ+]i was 
not accompanied by an appreciable r lease of histamine or 
PGD 2. For instance, stimulation of the mast cells with 10 
/xM ATP 4- and CaC12 resulted in only marginal his- 
tamine secretion and no detectable PGD 2 release despite a 
micromolar ise in [Ca2+] i (Table 1). Furthermore, the 
addition of CaC12 to store-depleted cells resulted in a 
86 C.M.C.J. van Haaster et al. / Biochimica et Biophysica Acta 1265 (1995) 79-88 
prolonged increase in [Ca 2+ ]i of about 300 nM, but not in 
the release of histamine or PGD 2 (Table 2). Typically, in 
both cases, the Ca 2+ responses of the mast cells consisted 
entirely of Ca 2÷ influx, whereas under conditions where 
significant amounts of histamine and PGD 2 were released, 
i.e., in mast cells activated with compound 48/80, thapsi- 
gargin or ionomycin, Ca z÷ influx was always accompa- 
nied by store depletion. Thus, these results suggest (intra- 
cellular signalling associated with) the influx of Ca 2÷ 
potentiates the release of histamine and PGD 2, but that the 
influx alone is insufficient to trigger these events. Whereas 
the additional factors required for exocytosis most likely 
include activation of protein kinase C [4,5] and/or of the 
newly identified G protein, Gi3 [6], the signalling factors 
required for eicosanoid formation are still less clear (see 
below). So far, our data suggest hat at least one of these 
factors is generated upstream or downstream of store 
depletion, but not downstream of Ca 2÷ influx. 
4.2. Differential release of  histamine and PGD 2 by acti- 
vated mast cells 
Mast cell-activating agonists may be divided into two 
types: agonists that are more efficient in evoking histamine 
secretion and agonists favouring PGD 2 release. We found 
that compound 48/80, known to act by stimulation of G 
proteins, is a relatively good histamine releaser, whereas 
thapsigargin and ionomycin stronger promoted PGD 2 re- 
lease (Table 1). This preferential action appeared to be 
independent of the presence or absence of external CaC12 
and, thus, of the amplitude of the agonist-evoked rise in 
[Ca2+]i . Since compound 48/80 evoked a Ca 2÷ signal 
that was shorter than that evoked by thapsigargin and 
ionomycin, it is possible that especially the duration, but 
not the amplitude, of the rise in [Ca 2÷ ]i is a decisive factor 
in promoting PGD 2 release. These results are consistent 
with earlier observations showing that G protein-activating 
compounds like substance P, compound 48/80 and 
bradykinin evoke in mast cells a relatively high histamine 
secretion [9,11], whereas Ca 2÷ ionophore A23187 and 
anti-immunoglobulin E were better generators of PGD 2 
[9,11,12,15]. Kawabe et al. [12] have provided good evi- 
dence that PGD 2, once produced, is rapidly released from 
the mast cells. This observation could be confirmed (data 
not shown). According to the presented ata, it was diffi- 
cult to classify ATP 4-, since this agent was hardly capable 
to release histamine or PGD 2 at a concentration f 10/xM, 
sufficient o elevate [Ca 2÷ ]i substantially (Table 1). 
When CaC12 was added to store-depleted mast cells, 
this resulted in the release of only minor amounts of 
histamine and PGD2, despite the persistently high level of 
[Ca2+]i reached. However, when CaCI 2 was added in 
combination with compound 48/80, the prolonged Ca 2÷ 
signal was accompanied by a high release of histamine as 
well as PGD 2 (Table 2). This partially contrasts with the 
low formation of PGD 2 and high secretion of histamine, 
when mast cells with full Ca 2+ stores were activated by 
compound 48/80 in the presence of CaCI 2 (Table 1). The 
histamine secretion is probably caused by the activation of 
protein kinase C by compound 48/80 [4,5]. It is tempting 
to suggest hat the high PGD 2 release may be a conse- 
quence of store depletion in combination with a prolonged 
Ca 2÷ signal: compound 48/80 allowed the store-depleted 
cells to re-empty the Ca 2÷ stores, once these were filled by 
the store-regulated influx pathway evoked by the addition 
of CaC12. Similar activation conditions were present, when 
cells with full stores were stimulated with thapsigargin or 
ionomycin in the presence of CaCI 2. 
4.3. Roles of  protein tyrosine kinases in the release of  
histamine and PGD 2 
We found that genistein and methyl-2,5-dihydroxycin- 
namate, two well-known inhibitors of protein tyrosine 
kinases, suppressed PGD 2 formation much better than 
histamine secretion in cells that were activated with iono- 
mycin (not shown), compound 48/80 and thapsigargin 
(Fig. 3). Although we do not have measured protein 
phosphorylation patterns directly, this suggests that tyro- 
sine kinases are more prominently involved in the reac- 
tions leading to eicosanoid formation than in those mediat- 
ing exocytosis. There is recent evidence that protein tyro- 
sine kinases are, indeed, involved in eicosanoid formation. 
For instance, from experiments with the same or similar 
tyrosine kinase inhibitors, it has been shown that tyrosine 
phosphorylation events contributed to the production of 
prostaglandin E 2 by murine macrophages [27] and to the 
mobilization of arachidonic acid in platelets [25] and in 
mast cells that were activated with stem cell factor [26]. 
Typically, genistein and methyl-2,5-dihydroxycinna- 
mate strongly influenced the relative amounts of histamine 
and PGD 2 that were released by the mast cells in response 
to thapsigargin: in the presence of the tyrosine kinase 
inhibitors thapsigargin changed from a good PGD 2 re- 
leaser to a relatively better histamine releaser (Fig. 3). In 
several other cell systems, including rat mastocytoma 
RBL-2H3 cells, it has been demonstrated that compounds 
like thapsigargin, ionomycin and A23187 are potent induc- 
ers of the phosphorylation at tyrosine of a whole series of 
proteins [28,31,45-47]. Thus, it is possible that the prop- 
erty of these Ca2+-mobilizing compounds to preferentially 
evoke PGD 2 release is related to their effect to stimulate 
protein tyrosine kinases. 
Studies with RBL-2H3 cells have shown that the secre- 
tion of histamine evoked by A23187, thapsigargin and 
anti-immunoglobulin E is modulated by tyrosine kinase or 
phosphatase inhibitors, suggesting these enzymes have also 
a regulatory function in ionophore- and antigen-evoked 
exocytosis [45,47]. In agreement with this, we found that 
in rat mast cells histamine secretion evoked by thapsigar- 
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gin and ionomycin was slightly reduced by protein tyro- 
sine kinase inhibition, in contrast o the secretion evoked 
by compound 48/80 which was not influenced (Fig. 3). 
The latter effect is well compatible with the evidence that 
signalling pathways involving protein tyrosine phospho- 
rylation in RBL-2H3 cells act largely independently of the 
activation by protein kinase C [48]. 
The cytoplasmic, 85-kDa phospholipase A 2 is consid- 
ered to mediate agonist-stimulated release of arachidonic 
acid in many cell types [49,50]. Recent data indicate that 
the activation of p85 phospholipase A 2 requires, besides 
elevation in [Ca 2+ ]i, a phosphorylation step which is puta- 
tively catalyzed by mitogen-associated protein kinases 
(MAP kinases) [50,51]. MAP kinases belong to a family of 
serine/threonine kinases which can be activated by phos- 
phorylation of their tyrosine and threonine residues and 
may serve as convergence points in intracellular signal 
transduction [52]. It is known that arachidonic acid mobi- 
lizing agents activate MAP kinases and cause increased 
phosphorylation of p85 phospholipase A 2 ([25,50] and 
refs. therein). For instance, in rat RBL-2H3 cells activated 
with A23187 or thapsigargin [45] and in cultured mouse 
mast cells activated with anti-immunoglobulin E or stem 
cell factor [53], MAP kinases or related enzymes appeared 
to be phosphorylated on tyrosine. Taken together, these 
findings lead to the conclusion that the potency of such 
agonists to favour the release of PGD 2 in mast cells might 
be a consequence of their ability to phosphorylate and 
activate MAP kinases and/or phospholipase A 2. This is a 
subject of further investigation. 
It has recently been proposed that besides phospho- 
lipase A e also a pathway involving phospholipase D may 
contribute to arachidonic acid liberation and eicosanoid 
formation in mast cells and RBL-2H3 cells [26,54,55]. In 
our experiments, we did not consider the involvement of 
either pathway in the release of PGD 2. Interestingly, how- 
ever, it was found by these authors that protein tyrosine 
kinases may also participate in the signalling events of the 
phospholipase D pathway. 
Taken together, our results indicate that in rat peritoneal 
mast cells the store-regulated influx of Ca 2÷ forms a major 
contribution to the agonist-evoked increase in [Ca 2+ ]i and 
is a potentiating factor in the release of histamine as well 
as PGD 2. However, the Ca z÷ influx as such appears to be 
insufficient o initiate these :release processes. Three fac- 
tors may contribute to a high release of PGD 2 by mast cell 
agonists: a relatively prolonged Ca 2+ signal, the process of 
store depletion and the phosphorylation at tyrosine of 
proteins involved in the phospholipase A2-mediated signal 
transduction cascade. It has been reported that in human 
platelets, activated with Ca 2÷ ionophore or thapsigargin, 
tyrosine phosphorylation a d dephosphorylation are con- 
trolled by the cytosolic and stored Ca 2÷ concentrations 
[46]. Hence, also in mast cells these three factors may not 
be mutually independent. A next task will be to unravel 
their interplay in the control of PGD 2 release. 
Acknowledgements 
The authors thank Jo Wierts and Jodil Willems for 
technical assistance in obtaining mast cells. Dr. Chris 
Reutelingsperger is acknowledged for the generous gift of 
methyl-2,5-dihydroxycinnamate. G.H. and J.W.M.H. ac- 
knowledge a grant from the Netherlands Heart Foundation 
(NHS 93.166). 
References 
[1] Metcalfe, D.D., Kaliner, M. and Donlon, M.A. (1981) CRC Crit. 
Rev. Immunol. 3, 23-74. 
[2] Ito, S., Narumiya, S. and Hayaishi, O. (1989) Prostagl. Leukotr. 
Essential Fatty Acids 37, 219-234. 
[3] Giles, H. and Left, P. (1988) Prostaglandins 35, 277-300. 
[4] Penner, R. (1988) Proc. Natl. Acad. Sci. USA 85, 9856-9860. 
[5] Gomperts, B.D., Churcher, Y., Koffer, A., Lillie, T.H.W., Tatham, 
P.E.R. and Whalley, T.D. (1991) Int. Arch. Allergy Appl. Immunol. 
94, 38-46. 
[6] Aridor, M., Rajmilevich, G., Beaven, M.A. and Sagi-Eisenberg, R. 
(1993) Science 262, 1569-1571. 
[7] Yamada, K., Okano, Y., Miura, K. and Nozawa, Y. (1987) Biochem. 
J. 247, 95-99. 
[8] Churcher, Y., Allan, D. and Gomperts, B.D. (1990) Biochem. J. 
266, 157-163. 
[9] Ennis, M., Barrow, S.E. and Blair, I.A. (1984) Agents Actions 14, 
397-400. 
[10] Chock, S.P., Rhee, S.G., Tang, L.C. and Schmauder-Chock, E.A. 
(1991) Eur. J. Biochem. 195, 707-713. 
[11] Levi-Schaffer, F. and Shalit, M. (1989) Int. Arch. Allergy Appl. 
Immunol. 90, 352-357. 
[12] Kawabe, H., Hayashi, H. and Hayaishi, O. (1987) Biochem. Bio- 
phys. Res. Commun. 143, 467-474. 
[13] Benyon, R.C., Robinson, C. and Church, M.K. (1989) Br. J. Phar- 
macol. 87, 898-904. 
[14] Ellati, S.G., Dahinden, C.A. and Church, M.K. (1994) J. Invest. 
Dermatol. 102, 803-806. 
[15] Church, M.K., E1-Lati, S. and Caulfield, J.P. (1991) Int. Arch. 
Allergy Appl. Immunol. 94, 314-318. 
[16] Lindau, M. and Gomperts, B.D. (1991) Biochim. Biophys. Acta 
1071, 429-471. 
[17] Lewis, R.A., Soter, N.A., Diamond, P.T., Austen, K.F., Oates, J.A. 
and Roberts, L.J.I. (1982) J. Immunol. 129, 1627-1631. 
[18] Mousli, M., Bronner, C., Landry, Y., Bockaert, J. and Rouot, B. 
(1990) FEBS Lett. 259, 260-262. 
[19] Wu, C.Y., Chen, C.F. and Chiang, C.F. (1993) Biochem. Biophys. 
Res. Commun. 192, 204-213. 
[20] Putney, J.W. and Bird, G.S.J. (1993) Endocr. Rev. 14, 610-631. 
[21] Sargeant, P., Clarkson, W.D., Sage, S.O. and Heemskerk, J.W.M. 
(1992) Cell Calcium 13, 553-564. 
[22] Tatham, P.E.R. and Lindau, M. (1990) J. Gen. Physiol. 95, 459-476. 
[23] Osipchuk, Y. and Cahalan, M. (1992) Nature 359, 241-244. 
[24] Kast, R., Furstenberger, G. and Marks, F. (1993) J. Biol. Chem. 268, 
16795-16802. 
[25] Nakashima, S., Chatani, Y., Nakamura, M., Miyoshi, N., Kohno, M. 
and Nozawa, Y. (1994) Biochem. Biophys. Res. Commun. 198, 
497-503. 
[26] Koike, T., Mizutani, T., Hirai, K., Morita, Y. and Nozawa, Y. 
(1993) Biochem. Biophys. Res. Commun. 197, 1570-1577. 
[27] Glaser, K.B., Sung, A., Bauer, J. and Weichman, B.M. (1993) 
Biochem. Pharmacol. 45, 711-721. 
[28] Murphy, C.T., Kellie, S. and Westwick, J. (1993) Eur. J. Biochem. 
216, 639-651. 
88 C.M.C.I. van Haaster et al. / Biochimica et Biophysica Acta 1265 (1995) 79-88 
[29] Akiyami, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S.-I., 
Itoh, N., Shibuya, M. and Fukami, Y. (1987) J. Biol. Chem. 262, 
5592-5595. 
[30] Umezawa, K., Hori, T., Tajima, H., lmoto, M., Isshiki, K. and 
Takeuchi, T. (1990) FEBS Lett. 260, 198-200. 
[31] Sargeant, P., Farndale, R. and Sage, S.O. (1993) J. Biol. Chem. 268, 
18151-18156. 
[32] Van Haaster, C.M.C.J., Engels, W., Lemmens, P.J.M.R., Hornstra, 
G. and van der Vusse, G.J. (1993) Biochim. Biophys. Acta 1167, 
147-154. 
[33] Heemskerk, J.W.M., Feijge, M.A.H., Rietman, E. and Hornstra, G. 
(1991) FEBS Lett. 284, 223-226. 
[34] Grynkiewicz, G., Poenie, M. and Tsien, R.Y. (1985) J. Biol. Chem. 
260, 3440-3450. 
[35] Van Haaster, C.M.C.J., Engels, W., Lemmens, P.J.M.R., Hornstra, 
G. and Van der Vusse, G.J. (1994) J. Chromatogr. 657, 261. 
[36] Van Haaster, C.M.C.J., Engels, W., Lemmens, P.J.M.R., Hornstra, 
G. and Van der Vusse, G.J. (1993) J. Chromatogr. 617, 233-240. 
[37] Wallenstein, S., Zucker, C.L. and Fleiss, J.L. (1980) Circ. Res. 47, 
1-9. 
[38] Putney, J.W. (1990) Cell Calcium 11, 611-624. 
[39] Hide, M. and Beaven, M.A. (1991) J. Biol. Chem. 266, 15221- 
15229. 
[40] Ali, H., Cunha-Melo, J.R., Saul, W.F. and Beaven, M.A. (1990) J. 
Biol. Chem. 265, 745-753. 
[41] Dar, O. and Pecht, I. (1992) FEBS Lett. 310, 123-128. 
[42] Hoth, M. and Penner, R. (1992) Nature 355, 353-356. 
[43] Fasolato, C., Hoth, M. and Penner, R. (1993) Pfliigers Arch. 423, 
225-231. 
[44] Randriamampita, C. and Tsien, R.Y. (1993) Nature 364, 809-814. 
[45] Santini, F. and Beaven, M.A. (1993) J. Biol. Chem. 268, 22716- 
22722. 
[46] Vostal, J., Jackson, W.L. and Shulman, N.R. (1991) J. Biol. Chem. 
266, 16911-16916. 
[47] Yu, K.T., Lyall, R., Jariwala, N., Zilberstein, A. and Haimovich, J. 
(1991) J. Biol. Chem. 266, 22564-22568. 
[48] Stephan, V., Benhamou, M., Gutkind, J.S., Robbins, K.C. and 
Siraganian, R.P. (1992) J. Biol. Chem. 267, 5434-5441. 
[49] Murakami, M., Kudo, I., Umeda, M., Matsuzawa, A., Takeda, M., 
Komada, M., Fujimori, Y., Takahshi, K. and Inoue, K. (1992) J. 
Biochem. 111, 175-181. 
[50] Lin, L.-L., Wartmann, M., Lin, A.Y., Knopf, J.L., Seth, A. and 
Davis, R.J. (1993) Cell 72, 269-278. 
[51] Nemenoff, R.A., Winitz, S., Qian, N.-X., Van Putten, V., Johnson, 
G.L. and Heasley, L.E. (1993) J. Biol. Chem. 268, 1960-1964. 
[52] Nishida, E. and Gotoh, Y. (1993)Trends Biochem. Sci. 18, 128-131. 
[53] Tsai, M., Chen, R.-H., Tam, S.-Y., Blenis, J. and Galli, S.J. (1993) 
Eur. J. Immunol. 23, 3286-3291. 
[54] Lin, P., Fung, W.J.C., Li, S., Chen, T., Repetto, B., Huang, K.S. and 
Gilfillan, A.M. (1994) Biochem. J. 299, 109-114. 
[55] Ishimoto, T., Akiba, S., Sato, T. and Fujii, T. (1994) Eur. J. 
Biochem. 219, 401-406. 
